Prevalence, characteristics, and risk factors of elevated triglyceride levels in US children

Clinical Pediatrics

Volumn 50, Issue 12, 2011, Pages 1103-1109

  Christian, Jennifer B ^a   Juneja, Maneesh X ^b   Meadowcroft, Amy M ^a   Borden, Spencer ^c   Lowe, Kimberly A ^d  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Exponent Health Sciences   (United States)

^d EXPONENT INC   (United States)

Author keywords

NHANES; pediatrics; triglycerides

Indexed keywords

CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID ESTER; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MENTAL DISORDERS; NUTRITION SURVEYS; PILOT PROJECTS; PREVALENCE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; UNITED STATES; YOUNG ADULT;

EID: 82355161709     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922811414286     Document Type: Article

References (15)

1. Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004 ; 110: 2678-2686 (Pubitemid 39453019)
2. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007 ; 115: 450-468
3. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000 ; 86: 943-949
4. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996 ; 3: 213-9 (Pubitemid 26266496)
5. Circulation. 2002 ; 106: 3143-3421
6. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998 ; 338: 1650-1656 (Pubitemid 28267909)
7. Prevalence of abnormal lipid levels among youths: United States, 1999-2006. MMWR Morb Mortal Wkly Rep. 2010 ; 59: 29-33
8. Nordstrom BL, Probst CA, Kling D, Reynolds MW. Epidemiology of hypertriglyceridemia in children. Pharmacoepidemiology and Drug Safety. 2007 ; 16: S247
9. Manlhiot C, Larsson P, Gurofsky RC, et al. Spectrum and management of hypertriglyceridemia among children in clinical practice. Pediatrics. 2009 ; 123: 458-465
10. Overview of NHANES survey design and weights. Hyattsville, MD: CDC ; 2010:
11. Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg/dL) hypertriglyceridemia in United States adults. Am J Cardiol. 2011 ; 107: 891-897
12. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008 ; 122: 198-208
13. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007 ; 115: 1948-1967 (Pubitemid 46598908)
14. National Cholesterol Education Program (NCEP): Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992 ; 89: 495-501
15. Browne B, Vasquez S. Pediatric dyslipidemias: prescription medication efficacy and safety. J Clin Lipidol. 2008 ; 2: 189-201 (Pubitemid 351673993)